Biology and treatment of myelodysplastic syndromes — developments in the past decade R. WillemzeW. E. FibbeJ. E. Landegent Review Article Pages: 107 - 115
Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis H. MaschekV. KaloutsiA. Georgii Original Article Pages: 117 - 122
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia — initial results A. GanserG. HeilD. Hoelzer Original Article Pages: 123 - 125
Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy U. MentzelH. VogtD. Hoelzer Original Article Pages: 127 - 129
Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine U. JehnV. Heinemann Original Article Pages: 131 - 134
IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study J. WaltherW. WilmannsH. H. Gerhartz Original Article Pages: 135 - 137
Dose-escalation study for the treatment of Hodgkin's disease V. Diehl Original Article Pages: 139 - 140
Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications M. R. ClemensK. FesseleM. E. Heim Original Article Pages: 141 - 146
Prevalence of HCV-RNA-positive blood donors and correlation to ELISA and RIBA status M. da Silva CardosoK. KoernerB. Kubanek Original Article Pages: 147 - 151
Acute agranulocytosis after prolonged high-dose usage of intravenous dipyrone — a different mechanism of dipyrone toxicity? J. SabbagaC. OsawaI. Cecconello Case Report Pages: 153 - 155
Severe aplastic anemia associated with seronegative community-acquired hepatitis C virus infection A. GruberL. GrillnerM. Björkholm Case Report Pages: 157 - 159
Possible selective effects of Interferon α-2b on a malignant clone in a case of polycythemia vera M. HinoE. FutamiH. Morii Case Report Pages: 161 - 162
Flow-cytometric enumeration of reticulocytes D. R. van BockstaeleJ. O'Connor Letter to the Editors Pages: 163 - 163
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study K. B. MillerK. KyungmannM. J. O'Connell Erratum Pages: 164 - 164